Receive Our Newsletter


Autologous cellular implants for organ therapies

Proven Effective

Minimally Invasive

Easy and Accessible

Undergoing clinical trial

You Are the Best Treatment

For years, the treatment for injured or damaged organs has been mostly linear. It begins with drugs designed to combat symptoms and slow further loss of function. Some organs respond better than others, but in many cases deterioration is followed eventually by more invasive treatments—dialysis for renal failure, for example—or even organ transplant. These procedures can be costly and often carry with them the unnecessary risk of complication, such as rejection of the transplant or serious infection.

The SVF-2 will soon make cellular therapy a safe, effective alternative. This procedure uses the patient’s own cells to create a healing environment within their body. The goal is to enable the body’s healing intelligence to repair damage and prevent further deterioration. Although the device and therapy are still undergoing a clinical trial, they show promise for a variety of organ therapies.

The Process is Simple


Using the SVF-2, a small sample of adipose tissue is extracted from the patient.



Using the SVF-2, a small sample of adipose tissue is extracted from the patient.



From that tissue, we isolate a heterogenous mixture of the essential stromal and vascular cells that enable natural tissue repair and regeneration.



The autologous cellular implant is then extracted from the SVF-2 device and then reintroduced into the body at the site of damage.

In more severe cases, surgical intervention may still be required, but for many, this procedure may present a long-term, non-surgical, regenerative solution.